It may be realized that understanding the pipelines among inflammation, insulin secretion and resistance, and dysregulation of lipid metabolism will be useful to explain how dairy protein-derived peptides IPP and VPP modulate different biochemical pathways and metabolic biomarkers associated with hyperglycemia and dyslipidemia. Here, IPP is linked to metabolic syndrome.